Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung Deposition of Tiotropium via HandiHaler in Healthy Subjects and COPD Patients
NCT02172456Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2002
- Primary completion
- Oct 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started May 2002; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02172456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172456.